
Raloxifene 60 mg Tablets
A tissue-selective SERM: blocks estrogen receptors in some tissues, acts estrogen-like in bone. A targeted option within monitored protocols.
Rx only — requires provider review
Included in this price
Strength
60 mgPurchase option
Supply
Raloxifene · 60 mg · 30 count
$69.00
The science
Raloxifene is a selective estrogen receptor modulator, or SERM. It blocks estrogen receptors in some tissues — such as breast tissue — while acting estrogen-like in others, including bone. That tissue-selective profile is what separates SERMs from aromatase inhibitors, which lower estrogen production across the board.
Providers may consider raloxifene in hormone-management protocols where receptor-level blockade in specific tissues is the goal, and its profile in other tissues fits the patient's broader picture. Choosing between raloxifene, tamoxifen, or a different approach is a clinical decision driven by your labs and history.
Raloxifene is used under medical supervision as part of a monitored plan. OpenDoseRx treatments are dispensed only after a licensed provider reviews your health intake and determines a prescription is appropriate for you.
How ordering works
Choose your strength
Pick the exact dose and pack size. You see the price before you commit — nothing is hidden until checkout.
A provider reviews your intake
Complete a short medical intake. An independent, licensed U.S. provider decides if it's appropriate — and if they decline, you're refunded in full.
Compounded and shipped
Approved orders are prepared by a licensed U.S. pharmacy — typically shipped within 1–2 business days of approval, then 3–5 business days in transit to your door.
Common questions
Pairs well with
Keep learning
What SERMs are: how tamoxifen and raloxifene are understood to modulate estrogen receptors
A neutral, mechanism-focused look at what selective estrogen receptor modulators are and how tamoxifen and raloxifene are understood to act as estrogen agonists in some tissues and antagonists in others.
How raloxifene works
A neutral, mechanism-focused look at raloxifene as a SERM and how its character at the estrogen receptor is understood to differ from one tissue to the next.
Tamoxifen vs. raloxifene: how these SERMs differ
A neutral, mechanism-focused comparison of how tamoxifen and raloxifene are understood to lean agonist or antagonist at the estrogen receptor across different tissues.